Regulatory Strategy and Commercialization Planning

This contract involves the development of a comprehensive regulatory roadmap aimed at securing FDA approval and formulating a commercialization strategy tailored for both military and civilian markets. The scope includes strategic engagement with regulatory bodies such as the FDA, as well as navigating Department of Defense acquisition pathways to ensure compliance and facilitate market entry. The initiative is positioned as a subcontract under the Defense Advanced Research Projects Agency, part of the Department of Defense, emphasizing its dual-use focus and alignment with defense acquisition processes. The contract was posted on May 1, 2026, with a response deadline of May 19, 2026, and is classified under the NAICS code 541618, which pertains to management consulting services. While specific location details and points of contact were not provided, the solicitation underscores the critical nature of integrating regulatory and commercialization planning within the defense sector, ensuring that the deliverables support both military needs and broader civilian applications.